Daphne Voineskos1, Daniel M Blumberger1, Reza Zomorrodi1, Nigel C Rogasch2, Faranak Farzan3, George Foussias1, Tarek K Rajji1, Zafiris J Daskalakis4. 1. Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada. 2. Brain and Mental Health Research Hub, School of Psychological Sciences, Monash Institute of Cognitive and Clinical Neuroscience, and Monash Biomedical Imaging, Monash University, Melbourne, Victoria, Australia. 3. Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario, Canada; School of Mechatronics Systems Engineering, Simon Fraser University, Burnaby, British Columbia, Canada. 4. Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada. Electronic address: Jeff.Daskalakis@camh.ca.
Abstract
BACKGROUND: The neurophysiology of major depressive disorder (MDD) has become a particular focus of transcranial magnetic stimulation (TMS) investigational studies. TMS combined with electroencephalography (TMS-EEG) affords a window to directly measure evoked activity from the dorsolateral prefrontal cortex (DLPFC), which is of considerable interest in MDD. Our study examined TMS-EEG responses from the DLPFC in persons with MDD compared with those in healthy participants. Specifically, we examined TMS-EEG markers linked to inhibitory and excitatory neurophysiological processes and their balance. METHODS: In all, 30 participants with MDD and 30 age- and sex-matched healthy participants underwent single-pulse TMS-EEG to assess inhibition and excitation from DLPFC. TMS-EEG waveforms were analyzed through global mean field amplitude. RESULTS: MDD participants demonstrated abnormalities in TMS-EEG markers in the DLPFC. Inhibitory measures-N45 and N100-were larger in the MDD group than in healthy participants (N45 [t = -4.894, p < .001] and N100 [t = -3.496, p = .001]). In a receiver operating characteristic analysis, N45 amplitude predicted depression illness state with 80% sensitivity, 73.3% specificity, and 76.6% accuracy (area under the curve = 0.829, p < .001). The global mean field amplitude area under the curve, a neurophysiological measure of cortical reactivity, was significantly larger in persons with MDD (t = -3.114, p = .003), as was P60 (t = -3.260, p = .002). In healthy participants, there was a positive correlation between inhibitory N45 and excitatory global mean field amplitude area under the curve (r = .711, p < .001) that was not present in persons with MDD (r = .149, p = .43), demonstrating a potential imbalance between inhibition and excitation in MDD. CONCLUSIONS: As the TMS-EEG waveform and its components index inhibitory and excitatory activity from the cortex, our results suggest abnormalities in these neurophysiological processes of DLPFC in persons with MDD.
BACKGROUND: The neurophysiology of major depressive disorder (MDD) has become a particular focus of transcranial magnetic stimulation (TMS) investigational studies. TMS combined with electroencephalography (TMS-EEG) affords a window to directly measure evoked activity from the dorsolateral prefrontal cortex (DLPFC), which is of considerable interest in MDD. Our study examined TMS-EEG responses from the DLPFC in persons with MDD compared with those in healthy participants. Specifically, we examined TMS-EEG markers linked to inhibitory and excitatory neurophysiological processes and their balance. METHODS: In all, 30 participants with MDD and 30 age- and sex-matched healthy participants underwent single-pulse TMS-EEG to assess inhibition and excitation from DLPFC. TMS-EEG waveforms were analyzed through global mean field amplitude. RESULTS:MDDparticipants demonstrated abnormalities in TMS-EEG markers in the DLPFC. Inhibitory measures-N45 and N100-were larger in the MDD group than in healthy participants (N45 [t = -4.894, p < .001] and N100 [t = -3.496, p = .001]). In a receiver operating characteristic analysis, N45 amplitude predicted depression illness state with 80% sensitivity, 73.3% specificity, and 76.6% accuracy (area under the curve = 0.829, p < .001). The global mean field amplitude area under the curve, a neurophysiological measure of cortical reactivity, was significantly larger in persons with MDD (t = -3.114, p = .003), as was P60 (t = -3.260, p = .002). In healthy participants, there was a positive correlation between inhibitory N45 and excitatory global mean field amplitude area under the curve (r = .711, p < .001) that was not present in persons with MDD (r = .149, p = .43), demonstrating a potential imbalance between inhibition and excitation in MDD. CONCLUSIONS: As the TMS-EEG waveform and its components index inhibitory and excitatory activity from the cortex, our results suggest abnormalities in these neurophysiological processes of DLPFC in persons with MDD.
Authors: Juliana Corlier; Andrew Wilson; Aimee M Hunter; Nikita Vince-Cruz; David Krantz; Jennifer Levitt; Michael J Minzenberg; Nathaniel Ginder; Ian A Cook; Andrew F Leuchter Journal: Cereb Cortex Date: 2019-12-17 Impact factor: 5.357
Authors: Nithya Ramakrishnan; Nicholas R E Murphy; Christopher P Walker; Valeria A Cuellar Leal; Jair C Soares; Raymond Y J Cho; Sudhakar Selvaraj Journal: Chronic Stress (Thousand Oaks) Date: 2019-07-23
Authors: Tomasz A Jarczok; Friederike Roebruck; Lena Pokorny; Lea Biermann; Veit Roessner; Christoph Klein; Stephan Bender Journal: Front Neurosci Date: 2021-03-12 Impact factor: 4.677
Authors: Patricio O'Donnell; Francis M Dijkstra; Ugur Damar; Lei Quanhong; Annika A de Goede; Lin Xu; Andres Pascual-Leone; Derek L Buhl; Rob Zuiker; Titia Q Ruijs; Jules A A C Heuberger; Paul MacMullin; Martin Lubell; Mahnaz Asgharnejad; Venkatesha Murthy; Alexander Rotenberg; Gabriel E Jacobs; Laura Rosen Journal: Transl Psychiatry Date: 2021-05-27 Impact factor: 6.222
Authors: Lucas Borrione; Helena Bellini; Lais Boralli Razza; Ana G Avila; Chris Baeken; Anna-Katharine Brem; Geraldo Busatto; Andre F Carvalho; Adam Chekroud; Zafiris J Daskalakis; Zhi-De Deng; Jonathan Downar; Wagner Gattaz; Colleen Loo; Paulo A Lotufo; Maria da Graça M Martin; Shawn M McClintock; Jacinta O'Shea; Frank Padberg; Ives C Passos; Giovanni A Salum; Marie-Anne Vanderhasselt; Renerio Fraguas; Isabela Benseñor; Leandro Valiengo; Andre R Brunoni Journal: Braz J Psychiatry Date: 2020-03-16 Impact factor: 2.697
Authors: Prabhjot Dhami; Sravya Atluri; Jonathan C Lee; Yuliya Knyahnytska; Paul E Croarkin; Daniel M Blumberger; Zafiris J Daskalakis; Faranak Farzan Journal: Cereb Cortex Date: 2020-06-01 Impact factor: 5.357